home Apparatus

J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer

  • Dec 13, 2024

Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China

  • Dec 12, 2024

Car-T From Carvykti, a Good Run Or a Bubble Fest

  • Dec 11, 2024

Inventory Of Fda-Approved Adc Drugs

  • Dec 10, 2024

Fujifilm Ai Technology Can Predict Whether Cognitive Disorders Will Progress To Alzheimer's Disease

  • Dec 09, 2024

Acs Med. Chem. Lett.| Protac-Targeted Jak2 Protein Kinase: a New Approach To Cancer Therapy

  • Dec 08, 2024

Germany Develops Faster, Cheaper New Crown Pcr Assay

  • Dec 07, 2024

Biyze For The Treatment Of Chronic Lymphocytic Leukaemia And Marginal Zone Lymphoma

  • Dec 06, 2024

"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial

  • Dec 05, 2024

World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us

  • Dec 04, 2024